---
title: "Virgin Galactic Holdings, Inc. Stock 12‑Month Price Target Cut to $3.27, Implies 25% Upside"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292775292.md"
description: "Virgin Galactic Holdings, Inc.'s average 12-month price target has been lowered from $3.51 to $3.27 by six analysts, implying a 25% upside from the July 14 close. The consensus rating remains 'Hold' among nine covering analysts, comprising two buys, four holds, and three sells."
datetime: "2026-07-15T13:20:13.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292775292.md)
  - [en](https://longbridge.com/en/news/292775292.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292775292.md)
generator: "portal-rs"
---

# Virgin Galactic Holdings, Inc. Stock 12‑Month Price Target Cut to $3.27, Implies 25% Upside

-   According to estimates from 6 analysts, Virgin Galactic Holdings, Inc. stock's average price target has fallen from $3.51 to $3.27, with forecasts ranging from $2 to $5 per share
-   Based on the Jul. 14 closing price, the updated target implies approximately 25% potential upside
-   Consensus rating remains at “Hold” across 9 covering analysts, with 2 Buys, 4 Holds and 3 Sells

Explore more price target data and ratings for Virgin Galactic Holdings, Inc. on the , and track all previous and future analyst recommendations for Virgin Galactic Holdings, Inc. in the dedicated News Flow.

**Disclaimer**

Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.

### Related Stocks

- [SPCE.US](https://longbridge.com/en/quote/SPCE.US.md)

## Related News & Research

- [Virgin Galactic wins court approval of derivative lawsuit settlement, gets $2.75 million payment](https://longbridge.com/en/news/296232934.md)
- [SPCE: Bookings oversubscribed, commercial flights delayed to Feb 2027, financials remain strong](https://longbridge.com/en/news/295717513.md)
- [Analyst Reiterates Buy on PG&E, Citing Regulatory Upside and Capital Flexibility with Unchanged $22 Price Target](https://longbridge.com/en/news/296216632.md)
- [This Definium Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday](https://longbridge.com/en/news/296231890.md)
- [What Are Wall Street Analysts' Target Price for Expeditors International Stock?](https://longbridge.com/en/news/296206707.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**